期刊文献+

心力衰竭患者住院病死率15年趋势分析 被引量:13

Long-term trends of in-hospital mortality in patients with heart failure:from 1993 to 2007
下载PDF
导出
摘要 目的调查15年间心力衰竭住院患者在院30 d病死率的变化趋势和住院日情况。方法选择1993年1月1日至2007年12月31日15年间的心力衰竭住院患者7319例(男4543例,女2776例),统计心力衰竭住院患者在院病死率及住院日,采用Kaplan-Meier生存曲线统计不同时段的生存时间。结果 15年间心力衰竭住院患者年龄呈增长趋势(P=0.000),平均住院日呈下降趋势(P=0.000)。在院30 d病死率从1993—1997年的7.0%,到1998—2002年的4.5%,再到2003—2007年的5.1%(P=0.002)。不同性别在不同时段的在院病死率差异无统计学意义。以心肌梗死、瓣膜性心脏病为病因的心力衰竭患者在院病死率下降极为显著(P<0.01)。Kaplan-Meier生存曲线显示,时段与病死率相关(2003—2007年比1993—1997年,HR 0.59,95%CI 0.46~0.76,P<0.001)。结论调整年龄后心力衰竭住院患者在研究时段30 d在院病死率呈显著下降趋势,平均住院日呈下降趋势,住院患者年龄呈显著增高趋势。 Objective To investigate the long-term trends of in-hospital mortality and length of stay in hospitalized patients with congestive heart failure (CHF). Methods A retrospective study was performed in 7319 patients (4543 males,2776 females) with diagnosis of CHF hospitalized from January 1, 1993 to December 31, 2007. In-hospital mortality, length of stay and survival rate were analyzed for all patients. Results During the 15-year period, the age of the patients hospitalized for CHF was increased significantly ( P = 0. 000 ) and the length of stay was reduced significantly ( P = 0. 000 ). In-hospital mortality was decreased from 7.0% during 1993 - 1997 to d. 5% during 1998 - 2002, and to 5. 1% during 2003 - 2007 ( P = 0. 002). There was no significant difference in gender of the patients with CHF. In-hospital mortality of myocardial infarction and valvular heart disease associated with CHF was decreased significantly (P 〈 0. O1 ) Kaplan-Meier survival curves showed that in-hospital mortality rate was associated with the study period (2003 -2007 vs. 1993 - 1997, HR O. 59, 95% CI O. 4643.76, P 〈 0. 001 ). Conclusions During the study period, in-hospital mortality is decreased significantly, length of stay is reduced and the age of the patients hospitalized for CHF is increased significantly.
出处 《中国心血管杂志》 2012年第4期276-279,共4页 Chinese Journal of Cardiovascular Medicine
关键词 充血性心力衰竭 在院病死率 趋势 Congestive heart failure In-hospital mortality Trends
  • 相关文献

参考文献8

二级参考文献57

  • 1马金萍,王林,党群,陈康寅,李永健,李喜元,陈树涛,丛洪良,张承宗,李广平.天津二所医院3858例慢性心力衰竭患者病因回顾性分析[J].中华心血管病杂志,2006,34(4):375-375. 被引量:5
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 3Teng TH, Firm J,Hobbs M,et al. Heart failure: Incidence, case fa tality, and hospitalization rates in Western Australia between 1990 and 2005[J]. Circ Heart Fail,2010,3(2)~236-243.
  • 4Komaida M, Anker SD, Charlesworth A, et al. The impact of new onset anaemia on morbidity and mortality in chronic heart fallure:Results from COMET[J]. Eur Heart J,2006,27(12) :1440-1446.
  • 5Harnaguehi S,Tsuehihashi MM, Kinugawa S, etal. Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan [J]. Cireulation, 2009, 73 : 1901-1908.
  • 6Avraham S, Moshe G, David S, et al. Atrial fibrillation and long-term prognosis in patients hospitalized for heart fallure:Results from heart failure survey in Israel (HFSIS)[J]. Eur Heart J,2010,31(3), 309-317.
  • 7Kawashiro N, Kasanuki H, Ogawa H, et al. Clinical characteristics and outcome of hospitalized patients with congestive heart failure resuits of the HIJCHF registry[J]. Circulation, 2008,72 : 2015-2020.
  • 8Silverberg DS, Wexler D, Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure [J]. Eur Heart Fail, 2002,4:681-686.
  • 9Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A.
  • 10Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162.

共引文献5092

同被引文献76

  • 1李菁雯,陈祥龙,孟祥智.虎杖及其提取物的研究进展[J].中医药学报,2011,39(3):103-106. 被引量:41
  • 2刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93. 被引量:1216
  • 3Krum H, Abraham WT. Heart failure [ J . Lancet, 2009, 373 ( 9667 ) : 941-955.
  • 4Wong CY, Chaudhry SI, Desai MM, et al. Trends in co- morbidity, disability and polypharmacy in heart failure [J]. Am J Med,2011,124(2):136-143.
  • 5Nokamura K, Miura D, Matsubara H, et al. Oxidative stress and calcium overload in heart failure [ J ]. Folia Pharmacologiea Japonica, 2012,140 ( 6 ) : 265 -269.
  • 6Radovanovic S, Savic-Radojevic A, Pljesa-Ercegovac M, et al. Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in pa- tients with chronic heart failure [ J 3. J Card Fail ,2012,18 (6) :493-501.
  • 7Aygen B, Celiker H,Dogukan A, et al. The effects of trim- etazidine on lipid peroxidation in patients with end-stage renal disease [ J ]. Methods Find Exp Clin Pharmacol, 2008,30(10) :757-760.
  • 8Dhote V, Balaraman R. Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia-reperfusion injury in rats [ J ]. Clin Exp Pharma- col Physiol, 2008,35 (5-6) : 630-637.
  • 9Pieper GM, Nilakantan V,Nguyen TK, et al. Reactive oxy- gen and reactive nitrogen as signaling molecules for caspase 3 activation in acute cardiac transplant rejection [ J ]. Antioxid Redox Signal, 2008,10 (6) : 1031-1040.
  • 10van Deel ED, Lu Z, Xu X, et al. Extracellular superoxide dismutasc protects the heart against oxidative stress and hypertrophy after myocardial infarction [ J ]. Free Radic Biol Med.2008.44(7) : 1305-1313.

引证文献13

二级引证文献176

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部